Director, Section of ALS and Related Disorders
Neurology
Dr. Erik P. Pioro, MD
|
|
Give Review
Dr. Erik P. Pioro practices Neurology. He has 3 awards "CMS Meaningful Use Stage 1 Certification", "Rhodes Scholarship" and "Barry Winovich Endowed Chair in ALS Research holder". Erik Pioro is a published doctor and has 60 publications published. The lastest was: 'Neuronal pathology in the wobbler mouse brain revealed by in vivo proton magnetic resonance spectroscopy and immunocytochemistry.' Erik P. Pioro, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Comparing Brain structural MRI and metabolic FDG-PET changes in patients with ALS-FTD: 'the chicken or the egg?' question.
- Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis.
- Distinct patterns of cortical atrophy in ALS patients with or without Dementia: An MRI VBM study.
- Use of Intrathecal Baclofen for Treatment of Severe Spasticity in Selected Patients With Motor Neuron Disease.
- T (2) relaxometry measurements in low spatial frequency Brain regions differ between fast spin-echo and multiple-echo spin-echo sequences.
- Diffusion Tensor Imaging Evaluation of Corticospinal Tract Hyperintensity in Upper Motor Neuron-Predominant ALS Patients.
- Structural basis for the wobbler mouse neurodegenerative disorder caused by mutation in the Vps54 subunit of the GARP complex.
- Cervical epidural injection complicated by syrinx formation: a case report.
- Lack of evidence of monomer/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis.
- Abnormal eye movements in Kennedy Disease.
- Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient.
- Familial ALS with SOD1 mutation misdiagnosed with polyradiculopathy and myopathy.
- Intrathecal baclofen for spasticity-related Pain in amyotrophic lateral sclerosis: efficacy and factors associated with Pain relief.
- Control of microglial neuroToxicity by the fractalkine receptor.
- Defining and diagnosing involuntary emotional expression disorder.
- Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals.
- A 25-year-old woman with hemiparesis and a solitary Brain lesion.
- Antioxidant therapy in ALS.
- Development, analysis, refinement, and utility of an interDisciplinary amyotrophic lateral sclerosis database.
- Proton magnetic resonance spectroscopy (1H-MRS) in ALS.
- Effects of cardiotrophin-1 (CT-1) in a mouse motor neuron Disease.
- Role of brain-derived neurotrophic factor in wobbler mouse motor neuron Disease.
- 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla.
- Neuronal pathology in the wobbler mouse Brain revealed by in vivo proton magnetic resonance spectroscopy and immunocytochemistry.
- MR spectroscopy in amyotrophic lateral sclerosis/motor neuron Disease.
- Genetic transfer of the wobbler gene to a C57BL/6J x NZB hybrid stock: natural history of the motor neuron Disease and response to CNTF and BDNF cotreatment.
- Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions.
- Animal models of ALS.
- Animal models of amyotrophic lateral sclerosis.
- Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy.
- NGF-mediated synaptic sprouting in the cerebral cortex of lesioned primate Brain.
- Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside GM1 treatment on primate nucleus basalis cholinergic neurons after neoco...
- Primate nucleus basalis of Meynert p75NGFR-containing cholinergic neurons are protected from retrograde degeneration by the ganglioside GM1.
- Detection of cortical neuron loss in motor neuron Disease by proton magnetic resonance spectroscopic imaging in vivo.
- Neocortical infarction in subhuman primates leads to restricted morphological damage of the cholinergic neurons in the nucleus basalis of Meynert.
- Loss of substance P and enkephalin immunoreactivity in the human substantia nigra after striato-pallidal infarction.
- Demonstration of substance P immunoreactivity in the nucleus dorsalis of human spinal cord.
- Combined thyrotroph and lactotroph cell hyperplasia simulating prolactin-secreting pituitary adenoma in long-standing primary hypothyroidism.
- Nerve growth factor-ganglioside interaction in the plasticity of Central cholinergic neurons.
- Purkinje cells of adult rat cerebellum express nerve growth factor receptor immunoreactivity: light microscopic observations.
- Loss of substance P immunoreactivity in the nucleus of the spinal trigeminal tract after intradural tumour compression of the trigeminal nerve.
- Immunoelectron microscopic evidence of nerve growth factor receptor metabolism and internalization in rat nucleus basalis neurons.
- Injury and repair of Central cholinergic neurons.
- Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central Nervous system. Effect of colchicine and correlation with the cholinergic s...
- Similarities in the ultrastructural distribution of nerve growth factor receptor-like immunoreactivity in cerebellar Purkinje cells of the neonatal and colchicine-trea...
- Substance P- and enkephalin-like immunoreactivities are colocalized in certain neurons of the substantia gelatinosa of the rat spinal cord: an ultrastructural double-l...
- Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of Discoveries, defects and disputes.
- A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.
- Imaging: MRS/MRI/PET/SPECT: pro.
- Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
- Motor neuronopathy with dropped hands and downbeat nystagmus: a distinctive disorder? A case report.
- A clinical trial of creatine in ALS.
- Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.
- Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.
- A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis.
- Cellular and subcellular localization of nerve growth factor receptor-like immunoreactivity in the rat CNS.
- Current concepts in the pharmacotherapy of pseudobulbar affect.
- Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases.
- Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect.
Schools
University Of Calgary Faculty Of Medicine
McGu University
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Non-Cosmetic Chemodenervation
Conditions Treated
- Alzheimer's Disease
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- View All
Doctors Specialties
- Clinical Neurophysiology
- Neurology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CareSource
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Guardian
- Medicare Advantage PFFS
- HealthSmart
- Choice Care PPO
- Kaiser Permanente
- Medicaid
- Medical Mutual of Ohio POS
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Paramount
- Priority Health
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Univera Healthcare
- UPMC Health Plan
- WellCare
- Wells Fargo Insurance
Awards
- CMS Meaningful Use Stage 1 Certification
- Rhodes Scholarship
- Barry Winovich Endowed Chair in ALS Research holder
Education
-
Cleveland Clinic Foundation -
Mayo School of Graduate Medical Education -
University of Calgary Faculty of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1154357499 | |
| NPPES Provider LastName | PIORO | |
| NPPES Provider FirstName | ERIK | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Neurology | |
| Total Claim Count | 364.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154357499 |
| Last Name Of The Provider | PIORO |
| First Name Of The Provider | ERIK |
| View All |
Similar Doctors
|
|
Dr. Daniel Ontaneda, MD |
|
|
Dr. Ajay Gupta, MD |
|
|
Dr. Mustafa Kahriman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Gerald E. Grossman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elaine Wyllie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert W. Shields Jr., MD |
|
|
Dr. Mei Lu, MD |
|
|
Dr. Herbert O. Ezugha, MD |
|
|
Dr. Camilo I. Garcia, MD |
|
|
Dr. Mohammad S. Alrajeh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard J. Leigh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meghna Kumar-Pelayo, MD |
|
|
Dr. Junaid H. Siddiqui, MD |
|
|
Dr. Hari P. Veedu, MD |
|
|
Narges Moghimi
This Doctor is OpenDoctor Recommended.
|
|
|
Daniel M. Young |